Navigation Links
Featured Stocks on Today's Edition of's 3-Minute Press Show: NPHC, PECD, PNRR

NEW YORK, April 15 /PRNewswire/ --'s 3-Minute Press Show is a daily video program hosted by reporter, Tracee Tolentino.

Shows air Monday through Friday on:'s 3-Minute Press Show features in-depth interviews with public company executives on their company and most recent press releases. The show is designed to provide viewers with insight into a company's most recent press release, and its impact on the company's growth.

The following executives were interviewed on today's show:

Rik Deitsch, CEO of Nutra Pharma Corp.

(OTC Bulletin Board: NPHC) (

Ralph Steckel, CEO of Pet Ecology Brands, Inc.

(Pink Sheets: PECD) (

Robert A. "Dutch" Hildebrand, Chief Financial Officer, Secretary and

Treasurer for Pinnacle Resources, Inc.

(Pink Sheets: PNRR) (

About WallStreet Direct, Inc.

WallStreet Direct, Inc. a wholly-owned subsidiary of Financial Media Group, Inc., owns and operates (, a leading source of up-to-the-minute business news, comprehensive financial tools and original multimedia content for the investment community. In addition to, WallStreet Direct owns and operates WallStRadio ( an online hub for business podcasts from well-known business news personalities and publishers. We have received ten thousand dollars from Nutra Pharma Corp. for media and advertising services. We have received ten thousand dollars, and twenty thousand free trading shares of PECD from a third party for media and advertising services for Pet Ecology Brands, Inc. We have received four hundred ninety five dollars from Pinnacle Resources, Inc. for the dissemination of this press release. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit

About Nutra Pharma Corp.

Nutra Pharma Corp. is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases. Nutra Pharma Corp. through its subsidiaries carries out basic drug discovery research and clinical development and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. The Company's subsidiary, ReceptoPharm, Inc., is developing these technologies for the production of drugs for HIV and Multiple Sclerosis ("MS"). The Company's subsidiary, Designer Diagnostics, is engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI). Nutra Pharma continues to identify and acquire intellectual property and companies in the biotechnology arena.

About Pet Ecology Brands, Inc.

Pet Ecology Brands, Inc. has developed a revolutionary patented cat litter that destroys urine odor, clumps, and is earth-friendly. The litter is ultra-lightweight and convenient to use (3 lbs works like 21 lbs of clay/ sand-based products), it is 100% flushable and safe for sewer and septic tank systems. Most importantly, it is completely safe for cats and our environment, and does not contain any sodium bentonite, as used in many competing brands. The design helps to protect the landfills, and yet does everything that clay litters do... and more. It has the ability to help indicate certain diseases commonly occurring in cats. The technique used is similar to that found in Merck's Veterinarian Manual. However, this litter not only warns of possible illness, but may also help indicate how far along the illness may be by the color the litter changes to, thereby providing the pet owner significant additional benefits and an early warning system concerning the cat's health.

About Pinnacle Resources, Inc.

Pinnacle Resources, Inc. engages in the exploration and development of natural resources. It engages in mining ocean diamonds, refining tantalum, and developing its vanadium/titanium property in South Africa. The company, through its interest in Orovi Ghana, Ltd., holds a gold prospecting right on the Riyadh concession in the central district of the Republic of Ghana.



SOURCE WallStreet Direct, Inc.; Nutra Pharma Corp.; Pet EcologyBrands
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. lifesDHA(TM) Featured in New Ricos(R) Cheese Sauce
2. Boydens Summit Practice Featured in the September Issue of New Jersey Business Magazine
3. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
4. Synvista Therapeutics to be Featured on
5. Astex Drug Candidates to be Featured at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
7. Marteks lifesDHA(TM) Now Featured in Two New Flavors of Rachels(R) Wickedly Delicious Yogurt from WhiteWave Foods
8. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
9. CT Laser Mammography Technology to be Featured at Interdisciplinary Breast Cancer Conference
10. Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race
11. CT Laser Mammography Technology to be Featured at European Congress of Radiology
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... announced today that it has closed the sale of ... to Guerbet (GBT- NYSE Euronext) in a transaction valued ... four manufacturing facilities and a total of approximately 1,000 ... the St. Louis area. This ...
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
Breaking Biology Technology:
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
Breaking Biology News(10 mins):